热门资讯> 正文
Travere Therapeutics申请混合货架产品
2024-08-02 05:47
- Travere Therapeutics (NASDAQ:TVTX) on Thursday said that it filed a prospectus for a mixed shelf offering, with the size undisclosed.
- The prospectus is not an offer to sell.
- SEC Filing.
More on Travere Therapeutics
- Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript
- Travere Therapeutics Q2 2024 Earnings Preview
- Travere gains on Novartis data for Filspari rival, Calliditas buyout
- Seeking Alpha’s Quant Rating on Travere Therapeutics
- Historical earnings data for Travere Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。